TrialNature medicine2025

Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial.

Georgina V Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.